Correlation Between Ultragenyx and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and DiaMedica Therapeutics, you can compare the effects of market volatilities on Ultragenyx and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and DiaMedica Therapeutics.
Diversification Opportunities for Ultragenyx and DiaMedica Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ultragenyx and DiaMedica is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Ultragenyx i.e., Ultragenyx and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Ultragenyx and DiaMedica Therapeutics
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the DiaMedica Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.78 times less risky than DiaMedica Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 439.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 127.00 from holding DiaMedica Therapeutics or generate 28.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultragenyx vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Ultragenyx |
| DiaMedica Therapeutics |
Ultragenyx and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultragenyx and DiaMedica Therapeutics
The main advantage of trading using opposite Ultragenyx and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Ultragenyx vs. DiaMedica Therapeutics | Ultragenyx vs. Lyra Therapeutics | Ultragenyx vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |